• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Hisamitsu Pharmaceutical Co Inc

+ Add to Watchlist


27.324 EUR 0.210 0.77%

As of 02:08:08 ET on 01/23/2015.

Snapshot for Hisamitsu Pharmaceutical Co Inc (HPX)

Open: 27.324 Day's Range: 27.324 - 27.324 Volume: 0
Previous Close: 27.114 52wk Range: 23.553 - 34.188 1-Yr Rtn: -15.71%

Stock Chart for HPX

No chart data available.
  • HPX:GR 27.324
  • 1D
  • 1M
  • 1Y
Interactive HPX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HPX

Current P/E Ratio (ttm) -
Estimated P/E(02/2015) 17.6177
Relative P/E vs. DAX -
Earnings Per Share (JPY) (ttm) -
Est. EPS (JPY) (02/2015) 205.7000
Est. PEG Ratio -
Market Cap (M EUR) 2,600.29
Shares Outstanding (M) 95.16
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.05%
Cash Dividend (JPY) 37.5000
Dividend Ex-Date 02/25/2015
5 Year Dividend Growth 1.91%
Next Earnings Announcement 04/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HPX

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for HPX

HISAMITSU PHARMACEUTICAL CO., INC. produces and sells pharmaceutical products. The Company's main product is anti-inflammatory analgesic plasters and poultices sold under the brand name Salonpas. Hisamitsu Pharmaceutical exports its products to North America and Southeast Asia. The Company also researches and develops antibacterial products through its related company, RRF.

Hirotaka NakatomiPresident/CEOKazuyo NakatomiExecutive Vice President
Kosuke SugiyamaSenior Managing DirectorTetsuo AkiyamaManaging Director
More Company Profile & Key Executives for HPX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil